B‐type natriuretic peptides: applications for heart failure management in 2005

R. Troughton,M. Richards
DOI: https://doi.org/10.1111/j.1445-5994.2005.00867.x
2005-07-01
Abstract:There is equimolar secretion of BNP and NT-ProBNP, hence plasma levels are tightly correlated but are higher for NT-ProBNP by five–tenfold, due mainly to its longer plasma half-life compared to BNP, which is actively metabolized by neutral endopeptidase and cleared by the NPR-C receptor. Levels of both peptides increase with age and greater renal dysfunction, are higher for women than men and lower in obesity. 4 In heart failure, BNP and NT-ProBNP levels increase in proportion to the severity of cardiac dysfunction and symptoms. 5 Levels reflect LV systolic and diastolic function as well as LV filling pressure and haemodynamically significant structural or valve lesions. 5–7
What problem does this paper attempt to address?